Scientific publications

• POSTER: ‘A two-stage prediction model for heterogeneous effects for many treatment options’ – Konstantina Chalkou (University of Bern) Graduate School for Health Sciences Symposium 2019, Parkhotel Gunten, Thun Switzerland  November 19 – 20, 2019 DOWNLOAD

• POSTER: ‘Flexible Generic Framework for Evidence Synthesis in Health Technology Assessment’ – Tasnim Hamza (University of Bern) Graduate School for Health Sciences Symposium 2019, Parkhotel Gunten, Thun Switzerland  November 19 – 20, 2019 DOWNLOAD

• POSTER (in Spanish): HTx: ‘Marco para la próxima generación de Evaluación de Tecnologías Sanitarias en Europa’ – M. Elena Hernando, Gema García-Sáez (Universidad Politécnica de Madrid), Annual Conference of the Biomedical Enginnering Spanish Society (CASEIB2019) 27-29 November 2019, Santander, Spain DOWNLOAD

• POSTER: ‘NEXT GENERATION HEALTH TECHNOLOGY ASSESSMENT TO SUPPORT PATIENT-CENTRED, SOCIETALLY ORIENTED, REAL-TIME DECISION-MAKING IN DIABETES: CLINICAL DECISION SUPPORT SYSTEMS/ADVISORS’ – G. Garcia-Sanchez (Universidad Politécnica de Madrid) International Conference on Advanced Technologies & Treatments for Diabetes, Madrid, 2020 DOWNLOAD

Presentations

‘A two-stage prediction model for heterogeneous effects for many treatment options’ Konstantina Chalkou (University of Bern, Switzerland) XXXIst Conference of the Austro-Swiss Region [ ROeS ] of the International Biometric Society (Lausanne, Switzerland, September 9-12, 2019) DOWNLOAD

‘The need for better HTA methodology for more complex and personalised medicine’ Wim Goettsch, (Utrecht University, The Netherlands) Pharmaceutical Pricing and Reimbursement (PPRI) Conference (Vienna, Austria October 23-24, 2019) DOWNLOAD

PR materials

HTx Introductory slide deck  DOWNLOAD

HTx Newsletter September 2019 DOWNLOAD

Project results

HTx Expert Forum meeting November 25, 2019 Barcelona (Spain) – Summary poster of results DOWNLOAD

HTx Deliverable 1.1: Systematic review on how (cost-) effectiveness of combinations of health technologies, individualised/personalised treatments and treatment pathways is currently being assessed by HTA bodies DOWNLOAD

HTx Deliverable 1.3: Review on treatment modalities for patient with myelodysplastic syndrome (MDS) DOWNLOAD

HTx Deliverable 1.4: Report describing the available data sources in relapsing-remitting Multiple Sclerosis case study 3 DOWNLOAD

HTx Deliverable 4.4: Overview of the development of the use of RWD including a review of national consensus methods currently developed DOWNLOAD